Health TrialsbyHealthPanel

Previously Untreated Locally Advanced (IIIB/IIIC) or Metastatic (IV) e Nsq NSCLC Without Actionable Genomic Alterations

1

Review clinical trials related to Previously Untreated Locally Advanced (IIIB/IIIC) or Metastatic (IV) e Nsq NSCLC Without Actionable Genomic Alterations. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Phase III Study of RC148 Plus Chemotherapy Versus Tislelizumab Plus Chemotherapy as First-Line Treatment for Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

To evaluate the efficacy and safety of RC148 plus platinum-based chemotherapy versus tislelizumab plus platinum-based chemotherapy in trial participants with previously untreated locally advanced (Stage IIIB/IIIC) or metastatic (Stage IV), non-squamous non-small cell lung cancer without actionable genomic alterations.

Participants needed: 540
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: RemeGen Co., Ltd.Updated: Sep 22, 2026Locations: 1
Eligibility criteria

1. Voluntarily agrees to participate in the study and provides written informed...

1. Histologically confirmed presence of any squamous NSCLC, small cell carcinoma...

Read more